|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2365 EUR | -2.47% |
|
-5.40% | +2.83% |
NOXXON Pharma has appointed Don deBethizy to the company's Supervisory Board. In his last position as President and Chief Executive Officer of Santaris Pharma A/S, deBethizy initiated and managed the successful acquisition of the company by Roche. He is currently on the Board of Directors of Newron Pharmaceuticals.
He will join the current Supervisory Board of NOXXON which consists of seven industry and investor representatives.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.83% | 7.5M | |
| +55.70% | 55.7B | |
| +41.08% | 39.91B | |
| -5.39% | 39.57B | |
| -5.56% | 28.16B | |
| +16.46% | 26.3B | |
| -20.56% | 18.94B | |
| +33.03% | 12.17B | |
| +25.85% | 12.12B | |
| +2.72% | 12.12B |
TME PHARMA N.V. 
